|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
20068100-TableS5
|
Human Leukemia Bomben10 212genes
|
GeneSigDB
|
3.747E-4
|
4.341E-2
|
2.723E-1
|
1.113E-1
|
2
|
143
|
2
|
M3366
|
Genes up-regulated in comparison of Th2cells versus induced regulatory T cell (Treg).
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.236E-4
|
4.341E-2
|
2.723E-1
|
2.149E-1
|
2
|
199
|
3
|
M7861
|
Genes down-regulated in CD4 [GeneID=920] T cells treated with IL1B and IL6 [GeneID=3553;3569] versus those also treated with TGFB1 [GeneID=7040].
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
4.341E-2
|
2.723E-1
|
2.171E-1
|
2
|
200
|
4
|
M8869
|
Genes down-regulated in common lymphoid progenitors versus CD4 [GeneID=920] T cells.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
4.341E-2
|
2.723E-1
|
2.171E-1
|
2
|
200
|
5
|
M8842
|
Genes down-regulated in multipotent progenitors versus common lymphoid progenitors.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
4.341E-2
|
2.723E-1
|
2.171E-1
|
2
|
200
|
6
|
M2196
|
Genes significantly de-regulated (p < 0.05) by MIR21 [GeneID=406991] in A172 cells (glioma).
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.517E-3
|
4.726E-2
|
2.964E-1
|
4.504E-1
|
2
|
289
|
7
|
M9565
|
Up-regulated genes whose expression correlates with copy number gains in pancreatic adenocarcinoma cell lines and primary tumor specimens.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.590E-3
|
4.726E-2
|
2.964E-1
|
4.723E-1
|
2
|
296
|
8
|
M12674
|
Genes down-regulated in MCF7 cells (breast cancer) engineered to conditionally express LMO4 [GeneID=8543] by a Tet Off system.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
2.227E-3
|
4.726E-2
|
2.964E-1
|
6.613E-1
|
2
|
351
|
9
|
16465392-Table1
|
Human Breast Mewani06 17genes raf1
|
GeneSigDB
|
3.238E-3
|
4.726E-2
|
2.964E-1
|
9.616E-1
|
1
|
15
|
10
|
M5754
|
Genes down-regulated more than two-fold in lymphoblastoid cell lines from European population compared to those from Asian population.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
4.530E-3
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
21
|
11
|
M13766
|
Genes within amplicon 5p15 identified in a copy number alterations study of 191 breast tumor samples.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.607E-3
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
26
|
12
|
16514666-Table2
|
Rat Immune Molloy06 46genes
|
GeneSigDB
|
6.037E-3
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
28
|
13
|
19118092-Table4
|
Mouse Lung not cancer Cavarra09 43genes
|
GeneSigDB
|
7.971E-3
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
37
|
14
|
18974375-TableS4
|
Human Lymphoma Chng09 50genes
|
GeneSigDB
|
8.186E-3
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
38
|
15
|
15300801-Table1
|
Human Breast Nagai04 46genes ERpos
|
GeneSigDB
|
8.400E-3
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
39
|
16
|
M1760
|
Genes down-regulated after Cre-lox knockout of LSD1 [GeneID=23028] in pituitary.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
8.400E-3
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
39
|
17
|
M2679
|
Genes down-regulated in HEK293 cells (kidney fibroblasts) expressing constitutively active form of CTNNB1 [Gene ID=1499] gene.
|
MSigDB C6: Oncogenic Signatures (v6.0)
|
9.259E-3
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
43
|
18
|
M10797
|
Genes whose expression peaked at 60 min after stimulation of HeLa cells with EGF [GeneID=1950].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
9.688E-3
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
45
|
19
|
14678982-Table3
|
Human Stomach Kim03 57genes UpRegulated
|
GeneSigDB
|
1.119E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
52
|
20
|
M18168
|
Genes up-regulated in MEF cells (embryonic fibroblast) isolated from NRAS [GeneID=4893] knockout mice.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.461E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
68
|
21
|
18927307-tableS4
|
Human Colon Allen08 124genes
|
GeneSigDB
|
1.674E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
78
|
22
|
M19891
|
Genes co-regulated in uterus during a time course response to progesterone [PubChem=5994]: SOM cluster 12.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.696E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
79
|
23
|
16909116-Table2
|
Mouse StemCell Castellano07 104genes
|
GeneSigDB
|
1.696E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
79
|
24
|
19174476-SuppTable1
|
Human Lung not cancer Howrylak09 100genes
|
GeneSigDB
|
1.909E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
89
|
25
|
M1666
|
Strongly down-regulated at 8-96 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.973E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
92
|
26
|
15257931-SuppTableC
|
Human Leukemia Teuffel04 125genes
|
GeneSigDB
|
2.185E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
102
|
27
|
M1917
|
Genes up-regulated in neural stem cells (NSC) at both 36 h and 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
2.312E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
108
|
28
|
M18762
|
'Late-TGFB1 signature': genes overexpressed in primary hepatocytes at a late phase of TGFB1 [GeneID=7040] treatment; is associated with a more invasive phenotype.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
2.334E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
109
|
29
|
M8803
|
Genes up-regulated in Foxp3-ires-GFP T reg (FOXP3+ [GeneID=50943]): B6 versus NOD background.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
2.418E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
113
|
30
|
M4113
|
Genes up-regulated in U2OS cells (osteosarcoma) upon knockdown of HDAC2 [GeneID=3066] by RNAi.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
2.440E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
114
|
31
|
M8929
|
Genes up-regulated in CD4 [GeneID=920] Th17 T cells: enriched versus negative.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
2.567E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
120
|
32
|
15486989-table2
|
Rat Prostate Reyes05 189genes
|
GeneSigDB
|
2.588E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
121
|
33
|
M8933
|
Genes up-regulated in CD4 [GeneID=920] T cells: naïve versus Th1.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
2.694E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
126
|
34
|
M6767
|
Genes down-regulated in atypical ductal hyperplastic tissues from patients with (ADHC) breast cancer vs those without the cancer (ADH).
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
2.863E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
134
|
35
|
19168792-TableS5
|
Human Leukemia Figueroa09 199genes
|
GeneSigDB
|
2.884E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
135
|
36
|
M8918
|
Genes up-regulated in CD44 low [GeneID=960] CD8 T cells: wildtype versus RC3H1 [GeneID=149041] knockout.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
2.884E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
135
|
37
|
M471
|
Genes down-regulated in NIH3T3 cells (fibroblast): control versus stimulated with IFN-b.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
2.884E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
135
|
38
|
M6085
|
Genes up-regulated in CD4 [GeneID=920] T cells activated by anti-CD3 and anti-CD28: IL-12 (2h) versus IL4 [GeneID=3565] (2h).
|
MSigDB C7: Immunologic Signatures (v6.0)
|
2.968E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
139
|
39
|
M16384
|
Genes down-regulated in MFCF-7 cells (breast cancer) upon stable autocrine expression of HG1 [GeneID=2688].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.032E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
142
|
40
|
M2113
|
Genes whose expression in brain significantly and negatively correlated with the duration of all psychiatric disorders studied.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.095E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
145
|
41
|
M442
|
Genes up-regulated in peripheral blood monocytes (PBMC): control versus IL-12 stimulation.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
3.158E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
148
|
42
|
M9106
|
Genes down-regulated in CD4 T conv: control versus over-expression of PBX1 and FOXP3 [GeneID=5087;50943].
|
MSigDB C7: Immunologic Signatures (v6.0)
|
3.284E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
154
|
43
|
M2872
|
Genes down-regulated in HEL cells (erythroleukemia) after knockdown of JAK2 [Gene ID=3717] gene by RNAi.
|
MSigDB C6: Oncogenic Signatures (v6.0)
|
3.347E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
157
|
44
|
19351846-SuppTable2
|
Human Prostate Wang09 181genes
|
GeneSigDB
|
3.431E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
161
|
45
|
M8121
|
Genes down-regulated in IL10 [GeneID=3586] knockout macrophages stimulated by IL10 [GeneID=3586] versus NFKB1 [GeneID=4790] knockout macrophages stimulated by IL10 [GeneID=3586] and LPS.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
3.452E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
162
|
46
|
M8949
|
Genes up-regulated in T conv cells from aged PPARG [GeneID=5468] knockout: visceral adipose tissue versus lymph node.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
3.495E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
164
|
47
|
M8926
|
Genes down-regulated in CD4 [GeneID=920] T cells: naïve versus Th1.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
3.495E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
164
|
48
|
M6853
|
Genes up-regulated in spleens: LPS versus monophosphoryl lipid A.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
3.558E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
167
|
49
|
M2990
|
Genes down-regulated in B lymphocytes with ZFX [GeneID=7543] knockout: control versus stimulated by anti-IgM for 2h.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
3.579E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
168
|
50
|
12714683-Table5
|
Human Breast Ma02 200genes grade
|
GeneSigDB
|
3.600E-2
|
4.726E-2
|
2.964E-1
|
1.000E0
|
1
|
169
|